Arcturus Therapeutics Holdings (ARCT) Change in Acquisitions & Divestments (2018)
Arcturus Therapeutics Holdings (ARCT) posted Change in Acquisitions & Divestments of -$5000.0 for Q4 2018, down 100.06% on a QoQ basis from $8.0 million in Q3 2018.
Arcturus Therapeutics Holdings (ARCT) Change in Acquisitions & Divestments (2018) Analysis & Trends
Arcturus Therapeutics Holdings' Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at -$5000.0 for Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.28 Bn | 463.49 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.49 Bn | 115.24 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.26 Bn | 61.51 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - |
| 8 | Argenx Se | 55.67 Bn | 50.48 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn |
| 10 | Arcturus Therapeutics Holdings | 161.00 Mn | -50.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -5,000.00 |
| Dec 31, 2018 | -5,000.00 |
| Sep 30, 2018 | 7.96 Mn |
| Sep 30, 2018 | 7.96 Mn |